Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sofie, Arnetorp"'
Autor:
Paul Williams, Timothy A Herring, Renata T C Yokota, Tiago Maia, Sudhir Venkatesan, James C Marcus, Gabriella Settergren, Sofie Arnetorp, Andrew Lloyd, Johan L Severens, James W Varni, Sharon Dixon, Lweendo Hamusankwa, Philip A Powell, Sylvia Taylor, John E Ware Jr, Marieke Krol
Publikováno v:
JMIR Research Protocols, Vol 13, p e52643 (2024)
BackgroundImmunocompromised individuals are known to respond inadequately to SARS-CoV-2 vaccines, placing them at high risk of severe or fatal COVID-19. Thus, immunocompromised individuals and their caregivers may still practice varying degrees of so
Externí odkaz:
https://doaj.org/article/23f1d01f1c044a7da43e749e345f3919
Autor:
Darush Attar-Zadeh, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Ekaterina Maslova, Yang Xu, Danny Gibson, Jennifer K Quint
Publikováno v:
BJGP Open, Vol 7, Iss 3 (2023)
Background: Poor asthma control is associated with high short-acting β2-agonist (SABA) use. Aim: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions in the UK. Desig
Externí odkaz:
https://doaj.org/article/665a0cc002ec47c2a96b4e583a651a3a
Autor:
Ritika Kapoor, Baudouin Standaert, Edmund J. Pezalla, Nadia Demarteau, Kelly Sutton, Eszter Tichy, George Bungey, Sofie Arnetorp, Klas Bergenheim, Duncan Darroch-Thompson, Wilhelmine Meeraus, Lucas M. Okumura, Renata Tiene de Carvalho Yokota, Ray Gani, Terry Nolan
Publikováno v:
Vaccines, Vol 11, Iss 2, p 377 (2023)
Healthcare decision-makers face difficult decisions regarding COVID-19 booster selection given limited budgets and the need to maximize healthcare gain. A constrained optimization (CO) model was developed to identify booster allocation strategies tha
Externí odkaz:
https://doaj.org/article/ec4a5dd6bae248789ad2961f7e24c9b7
Autor:
Eleanor Bell, Simon Brassel, Edward Oliver, Hannah Schirrmacher, Sofie Arnetorp, Katja Berg, Duncan Darroch-Thompson, Paula Pohja-Hutchison, Bruce Mungall, Stuart Carroll, Maarten Postma, Lotte Steuten
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1320 (2022)
The objectives of this research were to produce a macro-level overview of the global COVID-19 burden and estimate the value of access to COVID-19 vaccines. A targeted literature review collated evidence of the burden. Linear modelling and data analys
Externí odkaz:
https://doaj.org/article/8f3b9069b2b443eaa444c23b99b66e3c
Autor:
Jennifer K. Quint, Sofie Arnetorp, Janwillem W.H. Kocks, Maciej Kupczyk, Javier Nuevo, Vicente Plaza, Claudia Cabrera, Chantal Raherison-Semjen, Brandie Walker, Erika Penz, Ileen Gilbert, Njira Lucia Lugogo, Ralf J.P. van der Valk, Andrew Fong, Christina Qian, Caroline Fabry-Vendrand, Chantal Touboul, Dorota Brzostek, Ekaterina Maslova, Filip Surmont, Helena Goike, Hitesh Gandhi, J.C. Korevaar, Joseph Tkacz, Karissa Johnston, Keith Peres da Costa, L. van Dijk, M. Vervloet, Michael Pollack, Paul Hernandez, Silvia Boarino, Stephen G. Noorduyn, Wendy Beekman-Hendricks, Y.M. Weesie
Publikováno v:
2309.10
Journal of Allergy and Clinical Immunology: In Practice, 10(9), 2297-2309.e10. American Academy of Allergy, Asthma and Immunology
Journal of Allergy and Clinical Immunology: In Practice, 10(9), 2297-2309.e10. American Academy of Allergy, Asthma and Immunology
Background: Expert national/global asthma management recommendations raise the issue whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant inhaled corticosteroids (ICS) exists.Objective: To examine SABA and maintenanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f85f1f2dce410f743f44fb620b616c
http://hdl.handle.net/10044/1/96149
http://hdl.handle.net/10044/1/96149
Autor:
Sofie Arnetorp, Darush Attar, Jennifer K Quint, Toby Capstick, Keith Peres Da Costa, Eleni Rapsomaniki, Yang Xu, Deborah Leese
Publikováno v:
Airway pharmacology and treatment.
Autor:
Njira L Lugogo, Ileen Gilbert, Jennifer K Quint, Ralf J. P. van der Valk, Sofie Arnetorp, Chantal Raherison-Semjen, Santiago Quirce, Maciej Kupczyk, Christer Janson, Erika Penz, Silvia Boarino, Javier Nuevo, Janwillem W. H. Kocks
Publikováno v:
Airway pharmacology and treatment.
Background: Safety concerns around the use of as-needed short-acting β2-agonist (SABA) monotherapy in asthma management warrant evaluation. The SABa use IN Asthma (SABINA) programme captures the current global burden of SABA use. Objective: To exami
Autor:
Karen Coulton, Claudia Cabrera, Chloe I Bloom, Ralf J. P. van der Valk, Jennifer K Quint, Sofie Arnetorp, Cassandra Nan
Introduction Patients with asthma typically increase short-acting β2-agonists (SABA) use with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse outcomes. We evaluated, in a large population cohort, an association between SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640590ade1ab31ee94d2a516dd2a8a18
http://hdl.handle.net/10044/1/81432
http://hdl.handle.net/10044/1/81432
Autor:
Chloe I, Bloom, Claudia, Cabrera, Sofie, Arnetorp, Karen, Coulton, Cassandra, Nan, Ralf J P, van der Valk, Jennifer K, Quint
Publikováno v:
Advances in therapy. 37(10)
Patients with asthma typically increase short-acting βAs part of the SABINA (SABA use IN Asthma) global program, we conducted a retrospective longitudinal observational study (SABINA I) using UK primary care electronic healthcare records (Clinical P
Autor:
Ulf Holmgren, Barinder Singh, Sofie Arnetorp, E. De Nigris, M.K. Siddiqui, Claudia Cabrera, N Sharma
Publikováno v:
Clinical studies in COPD: new evidence to guide practice.
Introduction and objectives To review treatment guidelines for COPD and disease patterns across countries, and compare these with recommendations in the 2018 GOLD Report, with a focus on triple therapy. Methods A targeted Embase®/MEDLINE® literatur